Clinical Trial Update: Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating paclitaxel lipid suspension for platinum-resistant or refractory ovarian cancer and related platinum-resistant peritoneal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Carcinoma
• Serous Ovarian Cancer

Drugs mentioned

• Paclitaxel Lipid Suspension (paclitaxel lipid suspension)

Snippet

Sponsor: Jina Pharmaceuticals Inc. | Conditions: Platinum-Resistant Primary Peritoneal Carcinoma, Platinum Resistant High Grade Epithelial Ovarian Cancer | Phase 3 | Status: NOT_YET_RECRUITING